Source: DGNews  |  Posted 8 years ago

Oral fluoroquinolone antibiotic kills the increasingly resistant strep pneumoniae bacteria, the most common cause of lower respiratory tract infections

SOUTH SAN FRANCISCO, CA -- April 7, 2003 -- GeneSoft Pharmaceuticals, Inc., an emerging pharmaceutical company based in South San Francisco, today announced that the Food and Drug Administration (FDA) has approved Factive